Remove Clinical Trials Remove Legalization Remove Therapy
article thumbnail

The Ketamine Clinic Craze: Legalities and Possibilities

Canna Law Blog

In an even larger trend, the health care provider community seems to be exploring various alternative therapies and emerging medicines to improve quality of care. Still, for all its promise, would-be clinic owners, practitioners, and consumers may be confused about the legality of such clinics.

Therapy 113
article thumbnail

A Moral COMPASS to Treat Mental Health Disorders Using the Magic of Psilocybin

NewsMunchies

In the largest clinical trial to date, a new study conducted by the UK-based pharmaceutical company Compass Pathways shows that psilocybin or “magic” mushrooms can safely relieve depression. The trial included 233 patients from 10 countries in North America and Europe. Food and Drug Administration.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

This Psilocybin Patent Could Be a Really Big Deal

Canna Law Blog

The company is also running a phase IIb clinical trial of its patented formulation, COMP360, which we covered in a blog post back in 2018. In that post, I explained how the Food and Drug Administration (FDA) approval process works and why this trial is so interesting and important. Psilocybin!

article thumbnail

DEA Faces Lawsuit For Denying End of Life Patients the Right to Try Psychedelics Therapy

Veriheal

In the last 100 years, many of the plant therapies that were embraced in history were outlawed by governments around the world and replaced by lab-made synthetic drugs we label medicine. It wasn’t until the last several hundred years that how we could heal our bodies became regulated by government entities. A Push by Patients.

Therapy 65
article thumbnail

Filament administers psilocybin to 14 participants in Health Canada sanctioned clinical trial

Cannabis Law Report

A group of up-and-coming psychedelic therapists have now legally experienced the mind-bending effects of psilocybin mushrooms. The clinical trial involving the use of Filament’s psilocybin received approval from Health Canada and was conducted as part of ATMA Journey Centre’s psychedelic-assisted therapist training program.

article thumbnail

Final Phase of MDMA Clinical Trials Shows Drug Is 90% Effective at Treating PTSD

SpeedWeed

A first-of-its-kind Phase 3 clinical trial has found that MDMA-assisted therapy provided meaningful relief from PTSD symptoms in nearly 90 percent of study participants. The subjects were randomly divided into two groups, each of which received three individual sessions of talk therapy. Image via. View original article.

article thumbnail

Study: CBD “Promising” Therapy for Cocaine Addiction

CannaMD

A new review published by scientific journal, Pharmacology Biochemistry and Behavior , has found that marijuana cannabinoid, CBD, is a “promising” therapy for treating cocaine dependence. Exploring alternative therapies, researchers turned their attention to marijuana cannabinoid, cannabidiol – more commonly referred to as CBD.

Therapy 98